Oral Delivery (Focus Group - OrD)

(282) Aggregation Behavior of Sodium Caprate: Insights from Coarse-Grained Simulations and SAS Techniques

(445) Dual-Responsive HEMA-Based Hydrogels for Targeted Colonic Delivery of Metronidazole.

(447) Ticagrelor Amorphous Solid Dispersion tablets: formulation with Gelucire® 48/16

(448) Direct Compression of Co-Processed Mannitol-HPMC for Controlled Release Tablets

(449) Triple-strengthened formulation for oral delivery of liraglutide-loaded nanoparticles

(450) Klucel™ Xtend hydroxypropylcellulose (HPC) for Dual Active Diabetic Controlled Release Dosages

(451) Advancing Oral Delivery of Biologic Drugs: Overcome Formulation Challenges with Permeation Enhancers

(452) Designing MELTSOFT: User-Centric Dosage via Hot Melt Extrusion

(453) A190, a new PPARα agonist loaded microemulsion for chemotherapy-induced peripheral neuropathy

(454) Development of pH-responsive Hydrogel in Gastro-Resistant Capsules for Colon Targeted Drug Delivery

(455) Dissolution of Sodium Oxybate ER Drug Product (LUMRYZ) in Different Reconstitution Liquid Vehicles

(456) 3D Printed Bioinspired Mucoadhesive Oral Patch for Long-acting Naltrexone Delivery

(457) Efficient Manufacturing of Delayed Release Minitablets using a Seal and Enteric Coating Approach

(458) Alternative Reconstitution Soft Foods Vehicles for Sodium Oxybate Extended-Release Drug Product

(459) Early Phase Selection of a Controlled Release Amorphous Dispersion Formulation

(460) Harnessing the Power of Human Breast Milk to Boost Intestinal Permeability for Nanoparticles

(461) Identifying optimal process and formulation parameters for the TSWG of acetaminophen using L-HPC

(462) Enteric-coated spherical granules for dual delivery of orlistat & acarbose with diverging properties

(463) Exploring Orodispersible Films Containing the PROTAC ARV-110 in Solvent Casting using PVA

(464) 3D molded carbidopa stoppers for fix dose levodopa gastro retentive tube delivery system

(465) The influence of PEGylated surfactants on the colonic absorption of celecoxib from nano-emulsion

(466) Enabling Oral Delivery of Salmon Calcitonin via SNEDDS: Impact on Protection and Activity

(467) Zero-Order Drug Release from Push-Pull Osmotic Tablets in Varying Dissolution Media

(468) In-Vitro Evaluation of Different Marketed Brands of Metformin Tablets Using Quality Control Tests

(469) Nanoparticle-stabilized Pickering emulsion for oral vaccine delivery

(470) Effect of Hydroxypropyl Cellulose Grade on the Tablet Characteristics in Continuous Granulation

(471) Enhancing pH-responsive drug release in gastrointestinal environment by alginate–CMC/CAP microbeads

(471-A) Impact of HPMC and formulation parameters on the dissolution profiles of modified release tablets

(471-B) Formulation and Process Parameters Optimization in Chewable Tablet.